Hospital acquired native valve endocarditis caused by Acinetobacter calcoaceticus and treated with imipenem/cilastin.
A case of hospital acquired endocarditis due to Acinetobacter calcoaceticus in a severely burned patient is presented. Both aortic and mitral native valves were affected and the organism was resistant to most antimicrobial agents.
D000151:Acinetobacter Infections / Q000188:drug therapy*; D000328:Adult; D001021:Aortic Valve / Q000382:microbiology; D002056:Burns / Q000188:drug therapy; D015377:Cilastatin; D003428:Cross Infection / Q000188:drug therapy*; D003521:Cyclopropanes / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D004697:Endocarditis, Bacterial / Q000188:drug therapy*; D006801:Humans; D015378:Imipenem; D008297:Male; D008889:Military Personnel; D018805:Sepsis / Q000188:drug therapy; D013845:Thienamycins / Q000627:therapeutic use*; D014946:Wound Infection / Q000188:drug therapy
D003521:Cyclopropanes; D013845:Thienamycins; D015377:Cilastatin; D015378:Imipenem